Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 1

Conditions

Ovarian Neoplasms 5Endometrial Neoplasms 5Colorectal Neoplasms 4Breast Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Urogenital Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Pancreatic Neoplasms 1Neoplastic Syndromes, Hereditary 1Endometrial Hyperplasia 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

Early Intervention, Educational 6Oxaliplatin 5Methods 4Cisplatin 4pembrolizumab 3Trastuzumab 3Surveys and Questionnaires 3Specimen Handling 3Leucovorin 3Fluorouracil 3Carboplatin 3X-Rays 2Radiotherapy 2Observation 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Irinotecan 2Interleukin-12 Subunit p35 2Gemcitabine 2Cyclophosphamide 2Counseling 2Cetuximab 2Capecitabine 2Biopsy 2veliparib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Genetic Testing × Gynecologic × Clear all
NCT01850654 2018-06-28

OCCPI

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3,470 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡